No Data
No Data
Express News | Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer
B.Riley Financial Maintains Verastem(VSTM.US) With Buy Rating, Raises Target Price to $9
Verastem Price Target Raised to $9 From $7 at B. Riley
Express News | Verastem Inc : B. Riley Raises Target Price to $9 From $7
Verastem Oncology to Present at the Guggenheim SMID Cap Biotech Conference
Unlock the Full List